D-0465-2024 Class II Ongoing
FDA drug recall D-0465-2024 was initiated by Nomax Inc on Apr 19, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities. The recall status is ongoing. Affected quantity: 15,444 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- May 1, 2024
- Initiation Date
- Apr 19, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,444 cartons
Product description
FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-404-01.
Reason for recall
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 14776, Exp. 05/31/2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0465-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026